
PGY-4 Anatomic & Clinical Pathology @USFpathology | @EmoryMedicine Alum | '26-27 Dermpathology Fellow, USF/Moffitt
Tampa, Florida
Joined November 2022
- Tweets322
- Following506
- Followers285
- Likes845
Pinned Tweet
I'm so honored to receive the Dermatopathology Trainee World Cup 1st place for my presentation on cysts mimicking malignancies with Drs. Foulis and Gibbs! Had a great time, learned a lot, and met many amazing people @IntSocDermpath #ISDP2023 #PathTwitter #dermpath #dermtwitter
Myles McCrary, MD PhD retweeted
Grateful and honored to receive CAP’s 2026 Junior Member of the Year Award at #CAP26. It has been a wonderful meeting filled with learning, reconnecting with colleagues, and reflecting on the mentors and community who have shaped my journey in pathology. Thank you, @Pathologists!
Myles McCrary, MD PhD retweeted
See you this Saturday at Moffitt!
@MoffittNews @ZhaiJim
There's still time to register and join us for our Biomarker Diagnostics Panel.
Discussion will focus on the role of biomarkers in guiding treatment selection, supporting precision-based care and the next generation of targeted therapies.
Register today: flpath.org/events/EventDetai…
Myles McCrary, MD PhD retweeted
Real-World Experience With TRBC1 Immunohistochemistry Across Cutaneous... sciencedirect.com/science/ar…
#CTCL #pathologists #pathTwitter #dermpath #dermatology #dermtwitter #pathology @ModernPathology @TheUSCAP @MassGenBrigham
Myles McCrary, MD PhD retweeted
⏰ You are invited!
Please use the link to register.
This is a non-CME in person meeting. FREE registration.
flpath.org/events/EventDetai…
@MoffittNews @FLPathologists #PathX #DP #AI
Myles McCrary, MD PhD retweeted
⏰ I look forward to welcome you here!
flpath.org/events/EventDetai… – at Temple Terrace, FL
Myles McCrary, MD PhD retweeted
Full circle moment. I've been a researcher @MoffittNews for over 20 years and this Friday, my son Nathan will present his own research through Moffitt's High school math-oncology internship.
"Optimizing Ovarian Cancer Treatment Times Based on MGMT Circadian Rhythm."
So Proud!
Myles McCrary, MD PhD retweeted
We look forward to hosting you at Moffitt Cancer Center on Aug 22! @MoffittNews @USFpathology @FLPathologists @Pathologists @CAPA_comm
We are thrilled to welcome an outstanding lineup of speakers to the 5th Multidisciplinary Interactive Precision Medicine Symposium on Aug. 22 at Moffitt Cancer Center in Tampa.
Registration is free. Learn more and reserve your spot: flpath.org/events/EventDetai…
@MoffittNews
Myles McCrary, MD PhD retweeted
We are thrilled to welcome an outstanding lineup of speakers to the 5th Multidisciplinary Interactive Precision Medicine Symposium on Aug. 22 at Moffitt Cancer Center in Tampa.
Registration is free. Learn more and reserve your spot: flpath.org/events/EventDetai…
@MoffittNews
Myles McCrary, MD PhD retweeted
Tomorrow at SMB #ECMTB2026, Daniel Camacho-Gomez, PhD, will share the latest research using machine learning and clinical imaging to predict skin lesion evolution, with the goal of supporting earlier, more personalized treatment decisions in skin cancer. #MoffittECMTB2026
learn more ➡️ bit.ly/4grSdcc
Myles McCrary, MD PhD retweeted
People often say skin tumors aren’t serious. Show them this cutaneous squamous cell carcinoma grossly invading the skull.
Skin cancer can be destructive, disfiguring, and even life-threatening. Early diagnosis and treatment matter. #Pathology #Dermatopathology #SkinCancer #med
Myles McCrary, MD PhD retweeted
I’m thrilled to share that I’m starting a new position as a Dermatopathology Fellow at @UTMDAnderson 😃
Myles McCrary, MD PhD retweeted
#FollowFriday Meet James Saller, MD (@james_saller), a molecular pathologist whose work focuses on cancer biology and precision medicine. His research explores genomic, transcriptomic and proteomic biomarkers to better predict outcomes and guide treatment decisions. Follow him for insights into molecular pathology. #MoffittAmbassadors
Exciting news for #dermpath: fellowships are officially moving to the Match for positions beginning in 2028. A huge step towards a more transparent and applicant-centered process after years of advocacy by ASDP leaders!
@fungmaxwell @bahaiguy @asdptweets
onlinelibrary.wiley.com/doi/…
Myles McCrary, MD PhD retweeted
The American Society of Dermatopathology
5th Annual Dermatopathology Fellowship Forum Webinar
Ask the Experts! Everything you need to know about Dermatopathology fellowship and more…
Wednesday, August 12, 2026
7:00 – 8:00 p.m. CT
Learn more at asdp.org/ASDP/ASDPWeb/Young%….
Myles McCrary, MD PhD retweeted
Morning, Americas — greetings to the rest of the world!
Mixed tumor of skin 👇📢📢📢
🔬 Circumscribed dermal/subcutaneous tumor
🧫 Bilayered eccrine &/or apocrine ducts: luminal epithelial + outer myoepithelial cells
🌀 Cords and tubules in myxoid/chondromyxoid stroma
🦴 Cartilage or hyalinized matrix may be present
🧱 Squamous metaplasia and keratin-filled cysts can occur
⚠️ PLAG1-rearranged (about 1/2) #dermpath #dermatology #dermatologia #dermtwitter #pathology #pathologists #pathTwitter
Myles McCrary, MD PhD retweeted
The FSP Summer Pathology Conference starts one month from today!
Join colleagues for a weekend featuring expert faculty and practical education. Plus, activities like Pop Culture Popcorn. 🍿
🗓️ July 10-12
📍 Eau Palm Beach Resort & Spa
Learn more: flpath.org/summer-conference
Myles McCrary, MD PhD retweeted
Congratulations to Jonathan Zager, MD, on receiving an honorary doctorate from the University of Gothenburg’s Sahlgrenska Academy.
This recognition honors his contributions to melanoma research, regional cancer treatment, perfusion-based therapies and his longstanding collaboration with researchers at the University of Gothenburg, where a ceremony will be held this fall.
“Receiving this honorary PhD is a deeply humbling and meaningful honor,” said Dr. @jzager99. “I am extremely grateful to be recognized by such a distinguished institution and look forward to continued collaboration with Dr. @OlofssonBagge and his team (@goteborgsuni @SahlgrenskaAcad).”
Myles McCrary, MD PhD retweeted
#FollowFriday Dr. Ghulam Rasool’s work in machine learning advances data-driven cancer research @MoffittNews and beyond. His lab develops deep and machine learning models to help answer clinically relevant questions and optimize treatment decisions for personalized #cancer care. Go give him a follow @Gxrasool!
Myles McCrary, MD PhD retweeted
From #MoffittScientificSymposium, Aakash Tripathi, PhD, discusses a pan-cancer framework for multimodal data fusion in cancer classification and survival prediction. Findings showed pretrained foundation-model embeddings outperformed unimodal and de novo multimodal approaches, supporting scalable oncology modeling through the OncoFabric framework.





































